Approximate effect of maximum exercise in an athlete to shift the alveolar Pco2-ventilation response curve to a level much higher than normal. The shift, believed to be caused by neurogenic factors, is almost exactly the right amount to maintain arterial Pco2 at the normal level of 40 mm Hg both in the resting state and during heavy exercise.
increase in ventilation is usually great enough so that at first it actually decreases arterial Pco2 below normal, as shown in the figure. The presumed reason that the ventilation forges ahead of the buildup of blood carbon dioxide is that the brain provides an "anticipatory" stimulation of respiration at the onset of exercise, causing extra alveolar ventilation even before it is needed. However, after about 30 to 40 seconds, the amount of carbon dioxide released into the blood from the active muscles approximately matches the increased rate of ventilation, and the arterial Pco2 returns essentially to normal even as the exercise continues, as shown toward the end of the 1-minute period of exercise in the figure.
Figure 41-10 summarizes the control of respiration during exercise in still another way, this time more quantitatively. The lower curve of this figure shows the effect of different levels of arterial Pco2 on alveolar ventilation when the body is at rest—that is, not exercising. The upper curve shows the approximate shift of this ventilatory curve caused by neurogenic drive from the respiratory center that occurs during heavy exercise. The points indicated on the two curves show the arterial Pco2 first in the resting state and then in the exercising state. Note in both instances that the Pco2 is at the normal level of 40 mm Hg. In other words, the neurogenic factor shifts the curve about 20-fold in the upward direction, so that ventilation almost matches the rate of carbon dioxide release, thus keeping arterial Pco2 near its normal value. The upper curve of Figure 41-10 also shows that if, during exercise, the arterial Pco2 does change from its normal value of 40 mm Hg, it has an extra stimulatory effect on ventilation at a Pco2 greater than 40 mm Hg and a depressant effect at a Pco2 less than 40 mm Hg.
Possibility That the Neurogenic Factor for Control of Ventilation During Exercise Is a Learned Response. Many experiments suggest that the brain's ability to shift the ventilatory response curve during exercise, as shown in Figure 41-10, is at least partly a learned response. That is, with repeated periods of exercise, the brain becomes progressively more able to provide the proper signals required to keep the blood Pco2 at its normal level. Also, there is reason to believe that even the cerebral cortex is involved in this learning, because experiments that block only the cortex also block the learned response.
Voluntary Control of Respiration. Thus far, we have discussed the involuntary system for the control of respiration. However, we all know that for short periods of time, respiration can be controlled voluntarily and that one can hyperventilate or hypoventilate to such an extent that serious derangements in Pco2, pH, and Po2 can occur in the blood.
Effect of Irritant Receptors in the Airways. The epithelium of the trachea, bronchi, and bronchioles is supplied with sensory nerve endings called pulmonary irritant receptors that are stimulated by many incidents. These cause coughing and sneezing, as discussed in Chapter 39. They may also cause bronchial constriction in such diseases as asthma and emphysema.
Function of Lung "J Receptors." A few sensory nerve endings have been described in the alveolar walls in juxtaposition to the pulmonary capillaries—hence the name "J receptors." They are stimulated especially when the pulmonary capillaries become engorged with blood or when pulmonary edema occurs in such conditions as congestive heart failure. Although the functional role of the J receptors is not clear, their excitation may give the person a feeling of dyspnea.
Effect of Brain Edema. The activity of the respiratory center may be depressed or even inactivated by acute brain edema resulting from brain concussion. For instance, the head might be struck against some solid object, after which the damaged brain tissues swell, compressing the cerebral arteries against the cranial vault and thus partially blocking cerebral blood supply.
Occasionally, respiratory depression resulting from brain edema can be relieved temporarily by intravenous injection of hypertonic solutions such as highly concentrated mannitol solution. These solutions osmotically remove some of the fluids of the brain, thus relieving intracranial pressure and sometimes re-establishing respiration within a few minutes.
Anesthesia. Perhaps the most prevalent cause of respiratory depression and respiratory arrest is overdosage with anesthetics or narcotics. For instance, sodium pentobarbital depresses the respiratory center considerably more than many other anesthetics, such as halothane. At one time, morphine was used as an anesthetic, but this drug is now used only as an adjunct to anesthetics because it greatly depresses the respiratory center while having less ability to anesthetize the cerebral cortex.
An abnormality of respiration called periodic breathing occurs in a number of disease conditions. The person breathes deeply for a short interval and then breathes slightly or not at all for an additional interval, with the cycle repeating itself over and over. One type of periodic breathing, Cheyne-Stokes breathing, is characterized by slowly waxing and waning respiration occurring about every 40 to 60 seconds, as illustrated in Figure 41-11.
Basic Mechanism of Cheyne-Stokes Breathing. The basic cause of Cheyne-Stokes breathing is the following: When a person overbreathes, thus blowing off too much carbon dioxide from the pulmonary blood while at the same time increasing blood oxygen, it takes several seconds before the changed pulmonary blood can be transported to the brain and inhibit the excess ventilation. By this time, the person has already overventilated for an extra few seconds. Therefore, when the overven-tilated blood finally reaches the brain respiratory center, the center becomes depressed an excessive amount. Then the opposite cycle begins. That is, carbon dioxide increases and oxygen decreases in the alveoli. Again, it takes a few seconds before the brain can respond to these new changes. When the brain does respond, the person breathes hard once again, and the cycle repeats.
The basic cause of Cheyne-Stokes breathing occurs in everyone. However, under normal conditions, this mechanism is highly "damped." That is, the fluids of the blood and the respiratory center control areas have large amounts of dissolved and chemically bound carbon dioxide and oxygen. Therefore, normally, the lungs cannot build up enough extra carbon dioxide or depress the oxygen sufficiently in a few seconds to cause the next cycle of the periodic breathing. But under two separate conditions, the damping factors can be overridden, and Cheyne-Stokes breathing does occur:
1. When a long delay occurs for transport of blood from the lungs to the brain, changes in carbon dioxide and oxygen in the alveoli can continue for many more seconds than usual. Under these conditions, the storage capacities of the alveoli and pulmonary blood for these gases are exceeded; then, after a few more seconds, the periodic respiratory drive becomes extreme, and Cheyne-Stokes breathing begins. This type of Cheyne-Stokes breathing often occurs in patients with severe cardiac failure because blood flow is slow, thus delaying the transport of blood gases from the lungs to the brain. In fact, in patients with chronic heart failure, Cheyne-Stokes breathing can sometimes occur on and off for months.
2. A second cause of Cheyne-Stokes breathing is increased negative feedback gain in the respiratory control areas. This means that a change in blood carbon dioxide or oxygen causes a far greater change in ventilation than normally. For instance, instead of the normal 2- to 3-fold increase in ventilation that occurs when the Pco2 rises
3 mm Hg, the same 3 mm Hg rise might increase ventilation 10- to 20-fold. The brain feedback tendency for periodic breathing is now strong enough to cause Cheyne-Stokes breathing without extra blood flow delay between the lungs and brain. This type of Cheyne-Stokes breathing occurs mainly in patients with brain damage. The brain damage often turns off the respiratory drive entirely for a few seconds; then an extra intense increase in blood carbon dioxide turns it back on with great force. Cheyne-Stokes breathing of this type is frequently a prelude to death from brain malfunction.
Typical records of changes in pulmonary and respiratory center Pco2 during Cheyne-Stokes breathing are shown in Figure 41-11. Note that the Pco2 of the pulmonary blood changes in advance of the Pco2 of the respiratory neurons. But the depth of respiration corresponds with the Pco2 in the brain, not with the Pco2 in the pulmonary blood where the ventilation is occurring.
PCO2 of lung blood
Respiratory center excited
PCO2 of lung blood
Respiratory center excited
The term apnea means absence of spontaneous breathing. Occasional apneas occur during normal sleep, but in persons with sleep apnea, the frequency and duration are greatly increased, with episodes of apnea lasting for 10 seconds or longer and occurring 300 to 500 times each night. Sleep apneas can be caused by obstruction of the upper airways, especially the pharynx, or by impaired central nervous system respiratory drive.
Cheyne-Stokes breathing, showing changing Pco2 in the pulmonary blood (red line) and delayed changes in the Pco2 of the fluids of the respiratory center (blue line).
Obstructive Sleep Apnea Is Caused by Blockage of the Upper Airway. The muscles of the pharynx normally keep this passage open to allow air to flow into the lungs during inspiration. During sleep, these muscles usually relax, but the airway passage remains open enough to permit adequate airflow. Some individuals have an especially narrow passage, and relaxation of these muscles during sleep causes the pharynx to completely close so that air cannot flow into the lungs.
In persons with sleep apnea, loud snoring and labored breathing occur soon after falling asleep. The snoring proceeds, often becoming louder, and is then interrupted by a long silent period during which no breathing (apnea) occurs. These periods of apnea result in significant decreases in Po2 and increases in Pco2, which greatly stimulate respiration. This, in turn, causes sudden attempts to breathe, which result in loud snorts and gasps followed by snoring and repeated episodes of apnea. The periods of apnea and labored breathing are repeated several hundred times during the night, resulting in fragmented, restless sleep. Therefore, patients with sleep apnea usually have excessive daytime drowsiness as well as other disorders, including increased sympathetic activity, high heart rates, pulmonary and systemic hypertension, and a greatly elevated risk for cardiovascular disease.
Obstructive sleep apnea most commonly occurs in older, obese persons in whom there is increased fat deposition in the soft tissues of the pharynx or compression of the pharynx due to excessive fat masses in the neck. In a few individuals, sleep apnea may be associated with nasal obstruction, a very large tongue, enlarged tonsils, or certain shapes of the palate that greatly increase resistance to the flow of air to the lungs during inspiration. The most common treatments of obstructive sleep apnea include (1) surgery to remove excess fat tissue at the back of the throat (a procedure called uvu-lopalatopharyngoplasty), to remove enlarged tonsils or adenoids, or to create an opening in the trachea (tra-cheostomy) to bypass the obstructed airway during sleep, and (2) nasal ventilation with continuous positive airway pressure (CPAP).
"Central" Sleep Apnea Occurs When the Neural Drive to Respiratory Muscles Is Transiently Abolished. In a few persons with sleep apnea, the central nervous system drive to the ventilatory muscles transiently ceases. Disorders that can cause cessation of the ventilatory drive during sleep include damage to the central respiratory centers or abnormalities of the respiratory neuromuscular apparatus. Patients affected by central sleep apnea may have decreased ventilation when they are awake, although they are fully capable of normal voluntary breathing. During sleep, their breathing disorders usually worsen, resulting in more frequent episodes of apnea that decrease Po2 and increase Pco2 until a critical level is reached that eventually stimulates respiration. These transient instabilities of respiration cause restless sleep and clinical features similar to those observed in obstructive sleep apnea.
In most patients, the cause of central sleep apnea is unknown, although instability of the respiratory drive can result from strokes or other disorders that make the respiratory centers of the brain less responsive to the stimulatory effects of carbon dioxide and hydrogen ions. Patients with this disease are extremely sensitive to even small doses of sedatives or narcotics, which further reduce the responsiveness of the respiratory centers to the stimulatory effects of carbon dioxide. Medications that stimulate the respiratory centers can sometimes be helpful, but ventilation with CPAP at night is usually necessary.
Dean JB, Ballantyne D, Cardone DL, et al: Role of gap junctions in CO2 chemoreception and respiratory control. Am J Physiol Lung Cell Mol Physiol 283:L665, 2002.
Dutschmann M, Paton JF: Inhibitory synaptic mechanisms regulating upper airway patency. Respir Physiol Neuro-biol 131:57,2002.
Feldman JL, Mitchell GS, Nattie EE: Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci 26:239, 2003.
Forster HV: Plasticity in the control of breathing following sensory denervation. J Appl Physiol 94:784, 2003.
Hilaire G, Pasaro R: Genesis and control of the respiratory rhythm in adult mammals. News Physiol Sci 18:23, 2003.
Howard RS, Rudd AG,Wolfe CD, Williams AJ: Pathophysiological and clinical aspects of breathing after stroke. Postgrad Med J 77:700, 2001.
Jordan D: Central nervous pathways and control of the airways. Respir Physiol 125:67, 2001.
Kara T, Narkiewicz K, Somers VK: Chemoreflexes—physiology and clinical implications. Acta Physiol Scand 177: 377, 2003.
Morris KF, Baekey DM, Nuding SC, et al: Neural network plasticity in respiratory control. J Appl Physiol 94:1242, 2003.
Mortola JP, Frappell PB: Ventilatory responses to changes in temperature in mammals and other vertebrates. Annu Rev Physiol 62:847, 2000.
Richerson GB: Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 5:449, 2004.
Semenza GL: O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96:1173, 2004.
Sharp FR, Bernaudin M: HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5:437, 2004.
Taylor EW, Jordan D, Coote JH: Central control of the cardiovascular and respiratory systems and their interactions in vertebrates. Physiol Rev 79:855,1999.
West JB: Pulmonary Physiology—The Essentials. Baltimore: Lippincott Williams & Wilkins, 2003.
Wolk R, Shamsuzzaman AS, Somers VK: Obesity, sleep apnea, and hypertension. Hypertension 42:1067, 2003.
Young T, Skatrud J, Peppard PE: Risk factors for obstructive sleep apnea in adults. JAMA 291:2013, 2004.
Zuperku EJ, McCrimmon DR: Gain modulation of respiratory neurons. Respir Physiol Neurobiol 131:121, 2002.
Was this article helpful?
This ebook provides an introductory explanation of the workings of the human body, with an effort to draw connections between the body systems and explain their interdependencies. A framework for the book is homeostasis and how the body maintains balance within each system. This is intended as a first introduction to physiology for a college-level course.